Sign up
Quantellect · Congress · Trade Detail
CCXIChemoCentryx, Inc. (CCXI) [ST]
DemocratHouse

Josh Gottheimer bought ChemoCentryx, Inc. (CCXI) [ST] (CCXI)

Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 5 trades in ChemoCentryx, Inc. (CCXI) [ST] (CCXI) since 2021, 2 purchases and 3 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Josh Gottheimer bought $1,001 - $15,000 of ChemoCentryx, Inc. (CCXI) [ST] (CCXI) on April 19, 2022. Since that trade, CCXI is down -0.19% against the S&P 500 up +73.22%, an outperformance of -73.41%.

Across these filings, Josh Gottheimer has been a net seller of CCXI (a buy-to-sell ratio of 0.67). The most recent disclosed CCXI transaction shown was dated October 20, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CCXI trades
5
Disclosed Vol
$40K
Buys
2
40%
Sells
3
60%
Buy / Sell
0.67
ratio
First → Last
2021–2022

Josh Gottheimer's CCXI trades vs the price

CCXI is down -0.19% since Josh Gottheimer bought on April 19, 2022, versus +73.22% for the S&P 500.

Performance since this trade

Price change since trade
-0.19%
S&P 500 change since trade
+73.22%
Outperformance vs S&P 500
-73.41%

All Josh Gottheimer CCXI trades

TradedTypeSizeReturnEst. profit
October 20, 2022SELL$1,001 - $15,000N/A
August 11, 2022SELL$1,001 - $15,000N/A
April 19, 2022BUY$1,001 - $15,000N/A
March 15, 2022SELL$1,001 - $15,000N/A
December 2, 2021BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Josh Gottheimer & CCXI trading FAQ

Is it legal for Josh Gottheimer to trade ChemoCentryx, Inc. (CCXI) [ST] (CCXI) stock?

Yes. Members of Congress are allowed to trade individual stocks, including ChemoCentryx, Inc. (CCXI) [ST] (CCXI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Josh Gottheimer buy CCXI?

Josh Gottheimer disclosed a purchase of $1,001 - $15,000 of ChemoCentryx, Inc. (CCXI) [ST] (CCXI) on April 19, 2022, according to public STOCK Act filings.

How has CCXI performed since Josh Gottheimer's trade?

Since Josh Gottheimer bought CCXI on April 19, 2022, the stock is down -0.19%, versus +73.22% for the S&P 500 over the same period, an outperformance of -73.41%.

How many times has Josh Gottheimer traded CCXI?

Josh Gottheimer has disclosed 5 CCXI trades since 2021 (2 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CCXI trades?

Quantellect tracks every disclosed congressional trade in ChemoCentryx, Inc. (CCXI) [ST] (CCXI) on the ChemoCentryx, Inc. (CCXI) [ST] congressional trading page, which aggregates filings across all members of Congress.

Josh Gottheimer's CCXI tradesAll congressional filings for ChemoCentryx, Inc. (CCXI) [ST]Josh Gottheimer's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.